Nitya Pharma Private Limited

Nitya Pharma Private Limited - trading in Delhi, India. FY 2026 financials & compliance.
CIN U24232DL2004PTC131033 Incorporated 16 December 2004 ROC Delhi HQ Delhi, India
Active Private Limited Company trading
Data last updated
Revenue · FY 2025
₹26.48 Lakh
▼ 12% YoY
Net loss · FY 2025
₹17,297
Net margin -0.7%
EBITDA · FY 2025
₹2.57 Lakh
EBITDA margin 9.7%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹6.13 Lakh
Satisfied ₹15 Lakh
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings

About Nitya Pharma Private Limited

Data last updated:

Nitya Pharma Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 16 December 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC131033. Its GSTIN is 07AACCN0174F1ZS (Delhi).

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Rajesh Bhatia and Anu Bhatia.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 103 First Floor Vardhman A.C. Market, C.S.C Vigyan Vihar, Delhi, India – 110092.

As per the financials filed for FY 2025, the company reported a revenue of ₹26.48 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹17,297 (net margin -0.7%) and EBITDA of ₹2.57 Lakh (EBITDA margin 9.7%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 9% over five years.

As per MCA filings, the company has open charges of ₹6.13 Lakh and satisfied charges of ₹15 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Nitya Pharma Private Limited
CIN U24232DL2004PTC131033
Registration Number 131033
Incorporation Date 16 December 2004
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    103 First Floor Vardhman A.C. Market, C.S.C Vigyan Vihar, Delhi, India – 110092
  • Industry
    Trading, Other Wholesale, Wholesale
Comprehensive company report
Nitya Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Nitya Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Nitya Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Nitya Pharma Private Limited

The main business activity of Nitya Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Nitya Pharma Private Limited FY 2025 filings available

Nitya Pharma Private Limited reported revenue of ₹26.48 Lakh (down 12% YoY) for FY 2025.

Revenue · FY 2025
₹26.48 Lakh ▼ 12%
Net loss · FY 2025
₹17,297 margin -0.7%
EBITDA · FY 2025
₹2.57 Lakh margin 9.7%

Compounded Annual Growth Rate (CAGR) of Nitya Pharma Private Limited

Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 4%
5 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 9%
5 years · compounded
▲ 1%

Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 12% fall in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Nitya Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹2.57 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹17,297••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Nitya Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.7%••••••••••••••••
Net Profit Margin-0.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nitya Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Nitya Pharma Private Limited

Nitya Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mettec System India Private Limited₹26.5 Lakh (FY 2025)••••••••-59.0%••••Kalyan, Maharashtra, India
Jacf Industries Private Limited₹26.5 Lakh (FY 2024)••••••••296.0%••••Halol, Gujarat, India
Priya Broadcast Solutions Private Limited₹26.49 Lakh (FY 2022)••••••••••••Gazipur, Delhi, India
Parikshit Avocation Private Limited₹26.49 Lakh (FY 2025)••••••••894.0%••••Ghaziabad, Uttar Pradesh, India
Maya Rub-Chem Pvt Ltd₹26.48 Lakh (FY 2024)••••••••••••Kolkata, West Bengal, India
Nitya Pharma Private Limited this company₹26.48 Lakh (FY 2025)••••••••-12.0%••••Delhi, India
Ashoka Colour Chem Pvt Ltd₹26.48 Lakh (FY 2020)••••••••-49.0%••••Punjab, India
Sea Premium Private Limited₹26.48 Lakh (FY 2024)••••••••-74.0%••••Amritsar, Punjab, India
Sanyog International Pvt Ltd₹26.47 Lakh (FY 2025)••••••••9.0%••••New Delhi, Delhi, India
Eurocraze Pharma India Private Limited₹26.47 Lakh (FY 2023)••••••••-52.0%••••Delhi, India
Areesha Trading (India) Private Limited₹26.47 Lakh (FY 2020)••••••••-64.0%••••Mira Road, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Nitya Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Nitya Pharma Private Limited

Nitya Pharma Private Limited is audited by DEEPAK S KUMAR & CO. for the financial year 2017.

NameStatusAppointment DateCessation Date
DEEPAK S KUMAR & CO.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Nitya Pharma Private Limited

Nitya Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajesh BhatiaDirector16 Dec 200421 Years 9 MonthsCurrent
Anu BhatiaDirector16 Dec 200421 Years 9 MonthsCurrent

Ownership and Shareholding of Nitya Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Nitya Pharma Private Limited

Open charges
₹6.13 Lakh
Satisfied charges
₹15 Lakh
Breakdown by lending institutions
State Bank of India₹0.06 Cr
Latest charge details
DateLenderAmountStatus
10 Jul 2015State Bank of India₹6.13 LakhOpen
14 Feb 2009Ing Vysya Bank Limited₹15 LakhSatisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Nitya Pharma Private Limited

Employment history and EPFO contributions of people linked to Nitya Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Nitya Pharma Private Limited

Nitya Pharma Private Limited has 2 board changes on record since 2004: 2 appointments. The latest: Anu Bhatia was appointed as Director on 16 Dec 2004.

AGM
Nitya Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nitya Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with State Bank Of India of Rs. 6.13 Lakh registered on 10 Jul 2015 with Charge ID 10581389 was modified on 22 Feb 2024.
Charges
A charge registered on 14 Feb 2009 via Charge ID 10147238 with Ing Vysya Bank Limited was fully satisfied on 24 Nov 2015.
Charges
A charge with State Bank Of India amounted to Rs. 6.13 Lakh with Charge ID 10581389 was registered on 10 Jul 2015.
Charges
A charge with Ing Vysya Bank Limited amounted to Rs. 15.00 Lakh with Charge ID 10147238 was registered on 14 Feb 2009.
Appointed
Anu Bhatia was appointed as Director.
Appointed
Rajesh Bhatia was appointed as Director.
Incorporation
16 Dec 2004
Nitya Pharma Private Limited was registered on 16 Dec 2004 with Roc Delhi I & aged 21 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Nitya Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nitya Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nitya Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Nitya Pharma Private Limited

Nitya Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AACCN0174F1ZSDelhiActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nitya Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitya Pharma Private Limited

Nitya Pharma is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 16 December 2004 (22+ years old) and is registered under CIN U24232DL2004PTC131033.

Nitya Pharma reported revenue of ₹26.48 Lakh for FY 2025 (down 12% YoY).

Nitya Pharma has 2 current directors:

Nitya Pharma reported a net loss of ₹17,297 (net margin -0.7%) and EBITDA of ₹2.57 Lakh (EBITDA margin 9.7%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Nitya Pharma is -4% over three years and -9% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Nitya Pharma is 07AACCN0174F1ZS, registered in Delhi.

The CIN (Corporate Identification Number) of Nitya Pharma is U24232DL2004PTC131033. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nitya Pharma was incorporated on 16 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Nitya Pharma by revenue are Mettec System India Private Limited, Jacf Industries Private Limited, Priya Broadcast Solutions Private Limited, Parikshit Avocation Private Limited, Maya Rub-Chem Pvt Ltd and 5 more, all in the same principal business activity (Wholesale Trading).

Anu Bhatia was appointed as Director on 16 Dec 2004. Rajesh Bhatia was appointed as Director on 16 Dec 2004.

The registered office of Nitya Pharma is at 103 First Floor Vardhman A.C. Market, C.S.C Vigyan Vihar, Delhi, India – 110092.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available